| Bioactivity | OICR12694 (JNJ-65234637) TFA is an orally active inhibitor of B cell lymphoma 6 (BCL6)[1]. |
| Target | B cell lymphoma 6 (BCL6) |
| Name | OICR12694 TFA |
| CAS | 2360625-98-3 |
| Formula | C29H28ClF3N8O4.xC2HF3O2 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mamai A, et al. Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor. ACS Med Chem Lett. 2023 Jan 12;14(2):199-210. |